AlphaFold predicted structure
FOCAD · Q5VW36

Mean pLDDT
82.8/ 100
Confident
1,801 residues
Confidence breakdown
- Very high(≥ 90)23%
- Confident(70–90)66%
- Low(50–70)8%
- Very low(< 50)3%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
focadhesin
Annotations refreshed 1 month ago.
Moderate Evidence (Amber)
Cholestasis
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalPaediatric pseudo-obstruction syndrome
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownliver disease, severe congenital
type 2 diabetes mellitus
placental abruption
smoking initiation
diabetes mellitus
diverticular disease
pleural empyema
pneumothorax
bone Paget disease
obesity disorder
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Focadhesin
Required for the maintenance of SKIC2 and SKIC3 proteostatic levels in the liver. May be involved in the regulation of RNA degradation by the exosome complex (PubMed:35864190). Potential tumor suppressor in gliomas
Curated MONDO disease pages that list FOCAD among their top associated genes.
FOCAD · Q5VW36

Mean pLDDT
82.8/ 100
Confident
1,801 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0